Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.12.2022 | Case report

Dupilumab/prednisolone

Eosinophilic granulomatosis with polyangiitis and unmasking of disease: 7 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Wechsler ME, et al. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis. The Journal of Allergy and Clinical Immunology in Practice 10 : 2695-2709, No. 10, Oct 2022. Available from: URL: http://doi.org/10.1016/j.jaip.2022.05.019 Wechsler ME, et al. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis. The Journal of Allergy and Clinical Immunology in Practice 10 : 2695-2709, No. 10, Oct 2022. Available from: URL: http://​doi.​org/​10.​1016/​j.​jaip.​2022.​05.​019
Metadaten
Titel
Dupilumab/prednisolone
Eosinophilic granulomatosis with polyangiitis and unmasking of disease: 7 case reports
Publikationsdatum
01.12.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-28983-y

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Tadalafil

Case report

Pregabalin

Case report

Ceftriaxone